AI drug discovery faces its biggest test yet
Chemistry World - 31-Jul-2025InSilico’s lung drug could prove if AI can truly reshape drug discovery and development
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Director in Chemical Biology Therapeutics at Novartis Institutes for BioMedical Research (NIBR)
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He’s worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer’s, diabetes, osteoporosis and other diseases.
Visit website: https://www.science.org/action/doSearch?AllField=derek lowe
Details last updated 12-Apr-2024
InSilico’s lung drug could prove if AI can truly reshape drug discovery and development
Researchers improved immune response to new infections and reduced overall inflammation